Evidence map›Paper›PMID 26039929›Full record

Trial reportJournal of acquired immune deficiency syndromes (1999)2015

Impact of Patient-Selected Care Buddies on Adherence to HIV Care, Disease Progression, and Conduct of Daily Life Among Pre-antiretroviral HIV-Infected Patients in Rakai, Uganda: A Randomized Controlled Trial.

Gertrude Nakigozi, Fredrick E Makumbi, John B Bwanika, Lynn Atuyambe, Steven J Reynolds, Godfrey Kigozi, Fred Nalugoda, Larry W Chang, Valerian Kiggundu, David Serwadda and 3 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of acquired immune deficiency syndromes (1999), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. HIV Prevention Efforts and Incidence of HIV in Uganda.The New England journal of medicine · 2017
    Article
  11. A Framework for Health Communication Across the HIV Treatment Continuum.Journal of acquired immune deficiency syndromes (1999) · 2017
    Review
  12. Review
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Gertrude Nakigozi*Rakai Health Sciences Program, Kalisizo, Uganda; †School of Public Health, Makerere University College of Health Sciences, Kampala, Uganda; ‡Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; §Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, MD; ‖Division of Infectious Diseases, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD; ¶Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; #Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
Fredrick E Makumbi
John B Bwanika
Lynn Atuyambe
Steven J Reynolds
Godfrey Kigozi
Fred Nalugoda
Larry W Chang
Valerian Kiggundu
David Serwadda
Maria J Wawer
Ronald H Gray
Moses R Kamya

Funding

Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Richard E. Chaisson · 2012 to 2026
$67.0M
International Center for Excellence in Research (ICER) in Uganda: Impact of ARVsZIAAI001040 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI REYNOLDS, STEVEN · 2009 to 2025
$23.5M
International Training/Research in Population and Health, UgandaD43TW001508 · FIC · JOHNS HOPKINS UNIVERSITY · PI GRAY, RONALD H · 2000 to 2010
$2.1M
Male Circumcision and Use of Foreskin Tissues for HIV Prevention in UgandaD43TW009578 · FIC · JOHNS HOPKINS UNIVERSITY · PI GRAY, RONALD H · 2013 to 2017
$1.3M
FIC NIH HHS 2 D43 TW001508-10FIC NIH HHS D43 TW001508FIC NIH HHS D43 TW009578NIAID NIH HHS P30 AI094189
6 · The paper itself

Abstract

backgroundData are limited on effects of household or community support persons ("care buddies") on enrollment into and adherence to pre-antiretroviral HIV care. We assessed the impact of care buddies on adherence to HIV clinic appointments, HIV progression, and conduct of daily life among pre-antiretroviral therapy (pre-ART) HIV-infected individuals in Rakai, Uganda.

methodsA total of 1209 HIV-infected pre-ART patients aged ≥15 years were randomized to standard of care (SOC) (n = 604) or patient-selected care buddy (PSCB) (n = 605) and followed at 6 and 12 months. Outcomes were adherence to clinic visits, HIV disease progression, and self-reported conduct of daily life. Incidence and prevalence rate ratios and 95% confidence intervals (CIs) were used to assess outcomes in the intent-to-treat and as-treated analyses.

resultsBaseline characteristics were comparable. In the intent to treat analysis, both arms were comparable with respect to adherence to CD4 monitoring visits [adjusted prevalence risk ratio (adjPRR), 0.98; 95% CI: 0.93 to 1.04; P = 0.529], and ART eligibility (adjPRR, 1.00; 95% CI: 0.77 to 1.31; P = 0.946). Good conduct of daily life was significantly higher in the PSCB than the SOC arm (adjPRR, 1.08; 95% CI: 1.03 to 1.13; P = 0.001). More men (61%) compared with women (30%) selected spouses/partners as buddies (P < 0.0001). Twenty-two percent of PSCB arm participants discontinued use of buddies.

conclusionsIn pre-ART persons, having care buddies improved the conduct of daily life of the HIV-infected patients but had no effect on HIV disease progression and only limited effect on clinic appointment adherence.

Indexed as

Disease ProgressionHealth Services AdministrationRisk-TakingSocial SupportAdolescentAdultFemaleHIV InfectionsHumansMaleMiddle AgedPatient ComplianceUgandaYoung Adult

Identifiers

PMID26039929
PMCPMC4556592

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.